Clinical Trials List
2024-05-03 - 2030-10-31
Phase III
Terminated4
-
Trial Applicant
GILEAD SCIENCES HONG KONG LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- HSIN-YUN SUN Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- CHIEN-YU CHENG 無
- 陳正斌 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chun-Yu Lin 無
- Tun-Chieh Chen 無
- 張雅婷 無
- Chung-Hao Huang 無
- Shang-Yi Lin 無
- 陳昭儒 無
- Chun-Yuan Lee 無
- Yen-Hsu Chen 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
546 participants
